PierianDx Revenue and Competitors
Estimated Revenue & Valuation
- PierianDx's estimated annual revenue is currently $14.4M per year.
- PierianDx received $9.2M in venture funding in January 2016.
- PierianDx's estimated revenue per employee is $140,000
- PierianDx's total funding is $74M.
Employee Data
- PierianDx has 103 Employees.
- PierianDx grew their employee count by -65% last year.
PierianDx's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Software Architect | Reveal Email/Phone |
2 | VP Sales - Enterprise & Strategic Accounts | Reveal Email/Phone |
3 | VP, Commercial Development, EMEA | Reveal Email/Phone |
4 | VP - Product | Reveal Email/Phone |
5 | SVP, Operations | Reveal Email/Phone |
6 | Chief Business Officer | Reveal Email/Phone |
7 | Clinical Genomics Director | Reveal Email/Phone |
8 | Director Product Management | Reveal Email/Phone |
9 | Manager Administration | Reveal Email/Phone |
10 | Lab and Interpretation Services Operations Manager | Reveal Email/Phone |
PierianDx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2867.7M | 14324 | 0% | N/A | N/A |
#2 | $2.1M | 21 | 11% | N/A | N/A |
#3 | $0.9M | 11 | N/A | N/A | N/A |
#4 | $27.5M | 183 | -10% | $35M | N/A |
#5 | $245M | 1224 | 0% | $80M | N/A |
#6 | $14.4M | 103 | -65% | $74M | N/A |
#7 | $8.8M | 70 | 23% | N/A | N/A |
#8 | $17.4M | 124 | 4% | $28.7M | N/A |
#9 | $2.8M | 29 | 93% | N/A | N/A |
#10 | $5607.4M | 28609 | 7% | N/A | N/A |
What Is PierianDx?
Every year millions of people bet their lives on precision medicine. PierianDx is on a mission to make sure that bet pays off. At PierianDx we empower progressive health institutions and diagnostic laboratories to build world-class precision medicine programs. Our industry-leading molecular genomics technologies and expertise deliver the most integrated, trusted, and collaborative approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient's bedside, we drive the adoption of genomics in clinical care and accelerate the fight against cancer and other diseases. For more information, visit www.pieriandx.com or @PierianDx on Twitter.
keywords:Biotechnology,Healthcare,Medical Diagnostics
$74M
Total Funding
103
Number of Employees
$14.4M
Revenue (est)
-65%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PierianDx News
2bPrecise LLC, Syapse PierianDx Fabric Genomics, SOPHiA GENETICS SA, N-of-One Foundation Medicine Human Longevity Sunquest Information Systems...
... PierianDx Inc, Syapse Inc, Qiagen, Foundation Medicine Inc, 2bPrecise LLC, N-of-One Inc, Flatiron Health Inc, Abbott Laboratories,...
PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to $17.5 million by 2022 and 2023, subject to certain conditions. Th ...
ST. LOUIS--(BUSINESS WIRE)--Mar 2, 2021-- PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinforce the company’s position as the leading provider of c ...
PierianDx, a St. Louis-based clinical genomics informatics company, closed a $27m Series B funding round. The round was led by ATW Partners and SJF Ventures with participation from existing investors Health Catalyst Capital, Inova Health Systems, RTI International, and ARUP Laboratories. Found ...
Other Companies in Saint Louis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.7M | 106 | 5% | N/A |
#2 | $18.6M | 106 | 33% | N/A |
#3 | $28.6M | 106 | 23% | N/A |
#4 | $3.5M | 107 | 4% | N/A |
#5 | $21.9M | 107 | 6% | N/A |
PierianDx Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2016-01-08 | $9.2M | A | Health Catalyst Capital Management | Article |